Article Versions Notes

Berends C, Maggen C, Lok CAR, van Gerwen M, Boere IA, Wolters VERA, Van Calsteren K, Segers H, van den Heuvel-Eibrink MM, Painter RC, et al. Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy. Cancers. 2021; 13(6):1214. https://doi.org/10.3390/cancers13061214

Berends, Claudia, Charlotte Maggen, Christianne A. R. Lok, Mathilde van Gerwen, Ingrid A. Boere, Vera E. R. A. Wolters, Kristel Van Calsteren, Heidi Segers, Marry M. van den Heuvel-Eibrink, Rebecca C. Painter, and et al. 2021. "Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy" Cancers 13, no. 6: 1214. https://doi.org/10.3390/cancers13061214

Berends, C., Maggen, C., Lok, C. A. R., van Gerwen, M., Boere, I. A., Wolters, V. E. R. A., Van Calsteren, K., Segers, H., van den Heuvel-Eibrink, M. M., Painter, R. C., Gziri, M. M., & Amant, F. (2021). Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy. Cancers, 13(6), 1214. https://doi.org/10.3390/cancers13061214